Camlin Fine Sciences Ltd
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
- Market Cap ₹ 5,638 Cr.
- Current Price ₹ 300
- High / Low ₹ 324 / 93.4
- Stock P/E 126
- Book Value ₹ 48.0
- Dividend Yield 0.00 %
- ROCE 10.3 %
- ROE 5.06 %
- Face Value ₹ 1.00
Pros
- Promoter holding has increased by 1.08% over last quarter.
Cons
- Stock is trading at 6.22 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 9.70% over past five years.
- Company has a low return on equity of 1.18% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
509 | 558 | 489 | 534 | 721 | 892 | 1,049 | 1,187 | 1,412 | 1,682 | 1,613 | 1,667 | |
446 | 474 | 397 | 502 | 705 | 819 | 914 | 1,000 | 1,254 | 1,468 | 1,529 | 1,458 | |
Operating Profit | 63 | 84 | 92 | 32 | 16 | 73 | 135 | 187 | 158 | 213 | 84 | 208 |
OPM % | 12% | 15% | 19% | 6% | 2% | 8% | 13% | 16% | 11% | 13% | 5% | 12% |
9 | 9 | -1 | 14 | 12 | 14 | 3 | 5 | 33 | -4 | -34 | -202 | |
Interest | 25 | 24 | 24 | 31 | 32 | 41 | 48 | 42 | 41 | 66 | 70 | 100 |
Depreciation | 12 | 16 | 17 | 22 | 27 | 29 | 33 | 44 | 56 | 63 | 79 | 64 |
Profit before tax | 35 | 53 | 50 | -6 | -31 | 17 | 58 | 105 | 94 | 80 | -99 | -158 |
Tax % | 18% | -4% | 28% | -26% | -22% | 82% | 49% | 38% | 36% | 50% | 6% | 0% |
29 | 55 | 36 | -4 | -24 | 3 | 30 | 65 | 60 | 40 | -105 | -158 | |
EPS in Rs | 2.71 | 5.11 | 3.30 | -0.96 | -2.18 | 0.04 | 2.23 | 3.56 | 3.45 | 2.96 | -4.94 | -7.40 |
Dividend Payout % | 12% | 8% | 12% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 10% |
3 Years: | 6% |
TTM: | 3% |
Compounded Profit Growth | |
---|---|
10 Years: | -2% |
5 Years: | 8% |
3 Years: | -10% |
TTM: | 175% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 47% |
3 Years: | 46% |
1 Year: | 194% |
Return on Equity | |
---|---|
10 Years: | 4% |
5 Years: | 4% |
3 Years: | 1% |
Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9 | 10 | 10 | 10 | 12 | 12 | 12 | 13 | 16 | 16 | 17 | 19 |
Reserves | 84 | 125 | 167 | 202 | 359 | 359 | 391 | 631 | 732 | 804 | 848 | 883 |
150 | 160 | 180 | 331 | 373 | 461 | 539 | 550 | 646 | 801 | 683 | 681 | |
126 | 131 | 123 | 126 | 273 | 255 | 290 | 282 | 396 | 425 | 424 | 441 | |
Total Liabilities | 369 | 426 | 479 | 669 | 1,016 | 1,087 | 1,232 | 1,475 | 1,790 | 2,045 | 1,972 | 2,024 |
83 | 106 | 140 | 201 | 278 | 272 | 306 | 584 | 601 | 858 | 816 | 704 | |
CWIP | 22 | 3 | 25 | 8 | 14 | 59 | 179 | 24 | 215 | 43 | 46 | 10 |
Investments | 1 | 1 | 1 | 19 | 115 | 11 | 7 | 7 | 7 | 8 | 8 | 61 |
262 | 316 | 313 | 442 | 609 | 745 | 740 | 861 | 966 | 1,136 | 1,102 | 1,249 | |
Total Assets | 369 | 426 | 479 | 669 | 1,016 | 1,087 | 1,232 | 1,475 | 1,790 | 2,045 | 1,972 | 2,024 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
27 | 46 | 72 | -9 | -15 | -9 | 86 | 117 | 145 | 51 | 139 | 27 | |
-32 | -26 | -66 | -70 | -149 | -2 | -90 | -133 | -249 | -125 | -66 | -75 | |
-6 | -15 | -7 | 91 | 182 | 26 | 3 | 39 | 136 | 60 | -86 | 72 | |
Net Cash Flow | -12 | 4 | -1 | 13 | 18 | 15 | -1 | 23 | 32 | -14 | -13 | 24 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 73 | 74 | 56 | 99 | 104 | 86 | 88 | 83 | 77 | 66 | 65 | 72 |
Inventory Days | 145 | 184 | 311 | 277 | 207 | 219 | 204 | 200 | 178 | 255 | 216 | 226 |
Days Payable | 132 | 144 | 171 | 110 | 154 | 127 | 119 | 99 | 112 | 129 | 130 | 162 |
Cash Conversion Cycle | 85 | 114 | 196 | 266 | 157 | 178 | 173 | 184 | 143 | 192 | 151 | 136 |
Working Capital Days | 71 | 91 | 109 | 178 | 144 | 143 | 120 | 123 | 103 | 125 | 121 | 125 |
ROCE % | 28% | 28% | 24% | 5% | 0% | 7% | 11% | 13% | 10% | 10% | 1% | 10% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
27 May - Annual Secretarial Compliance Report confirming full regulatory compliance for FY 2024-25.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
26 May - Q4 FY25 results: 15% revenue growth, EBITDA up 12.5%, vanillin capacity at 45-50%, discontinued units abandoned.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
24 May - Newspaper Advertisement - Audited Financial Results 31.03.2025
- Annual General Meeting Scheduled On August 8, 2025 23 May
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
23 May - Audio recording of Q4 and FY25 financial results conference call available on company website.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Feb 2025TranscriptNotesPPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Jan 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Dec 2019TranscriptNotesPPT
-
Dec 2019TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
Feb 2019TranscriptNotesPPT
-
Feb 2019TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
May 2016TranscriptNotesPPT
Business Verticals